Global Cataracts Market Analysis

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Cataracts Market Analysis

  • Pharmaceutical
  • Oct 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • Cataract surgeries are becoming increasingly essential in modern ophthalmic care due to their proven ability to restore vision, enhance quality of life, and reduce the risk of falls and related complications, especially in the elderly
  • The surging demand for cataract treatment is driven by a combination of factors including the rising incidence of age-related eye disorders, technological advancements in intraocular lenses (IOLs), and improved access to surgical care across both developed and developing regions
  • North America dominated the cataracts market with the largest revenue share of 39.15% in 2024, to the region’s advanced healthcare infrastructure, early adoption of cutting-edge cataract surgical technologies, and favorable reimbursement policies. The U.S., in particular, continues to witness high surgical volumes, fueled by increased awareness, a growing elderly population, and the availability of premium intraocular lenses (IOLs)
  • Asia-Pacific is expected to be the fastest growing region with a CAGR of 9.2% in the cataracts market during the forecast period due to increasing urbanization, rising healthcare expenditure, expanding access to ophthalmic care, and government-supported initiatives to eliminate preventable blindness
  • The surgery segment dominated the cataracts market with a market share of 38.5% in 2024, owing to its status as the primary and most effective treatment option for cataracts

Filled Map Analysis